A detailed history of Emfo, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Emfo, LLC holds 100 shares of MRNA stock, worth $3,685. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$3,685
Previous $10,000 10.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$96.41 - $126.61 $48,205 - $63,305
-500 Reduced 83.33%
100 $10,000
Q2 2023

Aug 03, 2023

BUY
$118.5 - $160.53 $59,250 - $80,265
500 Added 500.0%
600 $72,000
Q4 2021

Jan 27, 2022

SELL
$225.82 - $368.51 $146,783 - $239,531
-650 Reduced 86.67%
100 $25,000
Q3 2021

Oct 26, 2021

SELL
$221.9 - $484.47 $11,095 - $24,223
-50 Reduced 6.25%
750 $289,000
Q2 2021

Jul 20, 2021

BUY
$129.91 - $234.98 $103,928 - $187,984
800 New
800 $188,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Emfo, LLC Portfolio

Follow Emfo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emfo, LLC with notifications on news.